SANA Diagnostics
AI-based Human Voice Analysis for Medical Diagnostics
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in April 2020 by Arnon Toussia Cohen, SANA Diagnostics operates with 1-10 employees. The company ceased operations in May 2022.
Business overview
SANA Diagnostics specializes in developing AI and signal processing algorithms for medical diagnostics through human voice analysis. The company's core technology is applied to identify conditions such as obstructive sleep apnea (OSA), with future product development targeting coronary artery disease, asthma, and potential coronavirus infection. SANA Diagnostics operates within the Digital Healthcare and Digital Medical Diagnostics sectors, serving both consumers and healthcare providers, including doctors and patients.
Log in to access full profile ›Company Intelligence Q&A
- What is SANA Diagnostics' primary focus?
- SANA Diagnostics focuses on developing AI-based human voice analysis for medical diagnostics, utilizing artificial intelligence and signal processing algorithms.
- When was SANA Diagnostics founded?
- SANA Diagnostics was founded in April 2020.
- What was the operational status of SANA Diagnostics?
- SANA Diagnostics ceased to operate in May 2022.
- Who founded SANA Diagnostics?
- SANA Diagnostics was founded by Arnon Toussia Cohen.
- Which medical conditions does SANA Diagnostics' technology aim to diagnose?
- SANA Diagnostics' initial product was designed to identify obstructive sleep apnea (OSA), with plans to expand to diagnosing coronary artery disease, asthma, and potentially coronavirus infection.